http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-814491-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
filingDate 1956-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1959-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-814491-A
titleOfInvention Lipid mobiliser
abstract A lipid mobilizer may be obtained by dialysing the plasma of stressed mammals and freeze drying the dialysate. Specified nammals are rat, dog, man and preferably horse. Specified stresses are subjection to sub-normal temperature above 0 DEG C., administration of a convulsant drug such as diisopropylfluorophosphate or cholic acid, injection of protamine, anti-kidney serum or preferably cortisone. The lipid mobilizer may be dissolved in pyrogen-free aqueous medium for parenteral administration. The lipid mobilizer has the property when injected into animals of producing hyperlipemia, hyperphagia and depleting fat deposits in the body. It is a non-protein solid, freely soluble in water and physiological salt solution, less soluble in methanol and insoluble in 95 per cent ethanol or acetone, non-extractable by ether from acid or alkaline aqueous solutions, dialysable through semi-permeable membranes against water, comprising a low molecular weight polypeptide as the active ingredient, free of steroids and giving a positive ninhydrin reaction.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11604026-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2758724-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10969171-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10539367-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11137206-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11740019-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10793327-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11634257-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11609042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9863699-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11609043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11747082-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10976105-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11067336-B2
priorityDate 1956-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA1KZ92
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887

Total number of triples: 45.